Glioblastoma (GBM) is the most common primary malignant brain tumor in adults. The
challenging problem in cancer treatment is to find a way to upregulate radiosensitivity of …

Despite advances in glioblastoma (GBM) therapy, prognosis of the disease remains poor
with a low survival rate. Cannabidiol (CBD) can induce cell death and enhance …

Radiotherapy combined with chemotherapy is the major treatment modality for human
glioblastoma multiforme (GBM). GBMs eventually relapse after treatment and the average …

In the present study, we found that CBD inhibited U87-MG and T98G cell proliferation and
invasiveness in vitro and caused a decrease in the expression of a set of proteins …

Introduction: Glioblastoma (GBM) is the most common invasive brain tumor composed of
diverse cell types with poor prognosis. The highly complex tumor microenvironment (TME) …

High-grade glioma is one of the most aggressive cancers in adult humans and long-term
survival rates are very low as standard treatments for glioma remain largely unsuccessful …

Recently, we have shown that the non-psychoactive cannabinoid compound cannabidiol
(CBD) induces apoptosis of glioma cells in vitro and tumor regression in vivo. The present …

Simple Summary Glioblastoma (GBM) is the most frequent primary brain tumor entity with
poor prognosis and resistance to current standard therapies. Cannabinoids, such as …

Cannabidiol (CBD), the major non-psychoactive compound found in cannabis, is frequently
used both as a nutraceutical and therapeutic. Despite anecdotal evidence as an anticancer …

Background Cannabidiol (CBD), a nonpsychoactive cannabinoid with a low toxicity profile,
has been shown to produce antitumor activity across cancers in part through selective …